News

LGC announces half year trading results

LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.  

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.

The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.

Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories

LGC today announced the appointment of Dr Mehrdad Tabrizi as Executive Vice President and General Manager for LGC Axolabs.

Five more soldiers who fell at the Battle of Fromelles more than 100 years ago have been identified using DNA analysis performed by LGC.

The first step in a partnership between the University of Leeds and the NML, the laboratory was launched on Friday, 31 March 2023 at a special event hosted Nexus, which features talks from Professors Julian Braybrook and Nick Plant, as well as a visit from the Mayor of West Yorkshire Tracy Brabin.

Leading manufacturer and supplier of analytical reference standards greatly complements LGC's current offering

After ten years with LGC, initially as Chief Executive Officer and most recently as Non-Executive Chair, Tim Robinson has announced that, as planned, he will be retiring from LGC to focus on public service and philanthropy.